Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.45% | 185.15 | 1.2% | $602.67m | |
| CELG | Celgene Corporation | -0.43% | 78.80 | 1.2% | $532.62m | |
| GILD | Gilead Sciences, Inc. | -0.63% | 71.07 | 0.9% | $518.63m | |
| BIIB | Biogen Inc. | -0.44% | 296.04 | 1.2% | $437.32m | |
| NKTR | Nektar Therapeutics | -5.39% | 52.85 | 5.6% | $412.99m | |
| SRPT | Sarepta Therapeutics, Inc. | -6.23% | 140.33 | 16.6% | $356.37m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.67% | 159.19 | 1.9% | $269.27m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.89% | 331.97 | 2.6% | $248.01m | |
| ILMN | Illumina, Inc. | -1.19% | 282.65 | 3.5% | $212.82m | |
| BLUE | Bluebird Bio, Inc. | -9.85% | 168.90 | 15.7% | $194.29m | |
| EXAS | Exact Sciences Corporation | -3.62% | 66.33 | 25.4% | $180.98m | |
| A | Agilent Technologies, Inc. | -0.40% | 62.79 | 1.5% | $178.44m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.40% | 127.57 | 2.0% | $159.93m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.61% | 99.03 | 4.4% | $141.99m | |
| INCY | Incyte Corporation | 2.12% | 74.03 | 2.5% | $133.28m |
Company Profile
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of innovative therapies for the treatment of cancer. Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Toronto, Canada.